| View |
|
BR-770
|
Interferon Alfa-2B (Human)
|
Shaferon
|
5 million I.U/mL
|
Solution For Injection (I.M./S.C.)
|
Prescription Drug (RX)
|
1 ml Pre-filled Glass Syringe (Box of 1's)
|
Immunostimulant
|
Beijing Kawin Technology Share- Holding Co., Ltd.
|
China
|
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Renewal
|
30 March 2021
|
19 November 2025
|
| View |
|
BR-771
|
Interferon Alfa-2B (Human)
|
Shaferon
|
3 million I.U/mL
|
Solution For Injection (I.M./S.C.)
|
Prescription Drug (RX)
|
1 mL Pre-filled Glass Syringe (Box of 1's)
|
Immunostimulant
|
Beijing Kawin Technology Share- Holding Co., Ltd.
|
China
|
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Renewal
|
30 March 2021
|
19 November 2025
|
| View |
|
BR-774
|
Interferon Beta-1A (Human)
|
Rebif
|
132 mcg (36 million I.U.)/1.5 mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL Pre-filled Type I Glass Cartridge (with Net Content of 1.5 mL) (Box of 4's)
|
-
|
Merck Serono S.p.A.
|
Italy
|
|
Merck, Inc.
|
|
-
|
18 February 2021
|
03 January 2026
|
| View |
|
BR-775
|
Interferon Beta-1A (Human)
|
Rebif
|
66 mcg (18 million I.U)/1.5 mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
3 mL pre-filled Type I glass cartridge (with net content of 1.5 mL) (Box of 4's)
|
-
|
Merck Serono S.p.A.
|
Italy
|
|
Merck, Inc.
|
|
-
|
08 March 2021
|
03 January 2026
|
| View |
|
BR-776
|
Rotavirus Vaccine (Live, Attenuated)
|
Rotarix
|
1.5 mL
|
Oral Suspension
|
Prescription Drug (RX)
|
3 mL (Net content: 1.5 mL) Sterile polyethylene squeezable tube with nozzle fitted with a tip seal and a tube cap (polypropylene) (Box of l’s and 10's)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Renewal
|
23 May 2022
|
18 May 2027
|
| View |
|
BR-778
|
Filgrastim
|
White-C
|
300 mcg/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Glass Vial (Box of 1's)
|
Immunostimulant
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
Renewal
|
30 March 2021
|
11 January 2026
|
| View |
|
BR-779
|
Epoetin Alfa
|
Eposino
|
10,000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (Rx)
|
1 mL x Pre-filled Glass Syringe (Box of l's)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
N/A
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
Regular Renewal (Revalidation)
|
24 January 2023
|
18 January 2026
|
| View |
|
BR-783
|
Human Papillomavirus Vaccine [Types 16 and 18]
(Recombinant, adjuvanted, adsorbed)
|
Cervarix
|
Formulation: 1 dose (0.5 mL) contains: Human Papillomavirus type 16 Ll protein*..............20 mcg Human Papillomavirus type 18 L1 protein*... ...........20 mcg
*adjuvanted by AS04 containing 3-O-desacyl-4-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3]
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
0.5 mL in 3 mL Type I glass vial (Box of 10's and 100's)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
-
|
27 April 2022
|
23 March 2027
|
| View |
|
BR-785
|
Measles and Rubella Vaccine (Live, Attenuated)
|
None
|
FORMULATION: After reconstitution, each dose (0.5 mL) contains: Measles virus (Edmonston-Zagreb strain) live,
attenuated.......... ......not less than 1000 CCID 50 Rubella virus (Wistar RA 27/3 strain) live, attenuated ...... ......not less than 1000 CCID 50
|
Powder for Injection (SC)
|
Prescription Drug (RX)
|
In a box of 100's, 50 Type I amber glass vial + 50
Type I colorless glass ampoule x 5 mL (Sterile Water for Injection as diluent)
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
N/A
|
Medical Vaccines Online Deliveries
|
Medical Vaccines Online Deliveries
|
-
|
08 February 2022
|
04 March 2025
|
| View |
|
BR-789
|
Hepatitis B Immunoglobulin (Human)
|
HyperHEP B S/D
|
(See formulation in reverse side)
|
Solution for Injection (IM)
|
Prescription Drug (Rx)
|
Single dose: 1mL pre-filled glass syringe (Box of 1's)
|
Immunoglobulins
|
Grifols Therapeutivs Inc.
|
United States of America
|
|
GB Distributors, Inc.
|
GB Distributors, Inc.
|
Renewal
|
23 June 2024
|
17 June 2029
|
| View |
|
BR-795
|
Clostridium botulinum Type A Neurotoxin Complex
|
Cunox
|
100units
|
Lyophilized Powder for Injection (IM)
|
Prescription Drug (RX)
|
Single dose. Type I glass vial (Box of 1’s)
|
Muscle Relaxant
|
Medytox Inc.
|
Korea
|
N/A
|
STADA Philippines Inc.
|
STADA Philippines Inc.
|
Renewal
|
23 May 2022
|
19 April 2026
|
| View |
|
BR-797
|
Enoxaparin (as Sodium)
|
Clexane
|
4000 IU (equivalent to 40 mg)/0.4 mL
|
Solution For Injection (S.C.)
|
Prescription Drug (RX)
|
0.4 mL in 0.5 mL Pre-filled Glass Syringe with
Needle (Box of l's and 2's)
|
-
|
Sanofi Winthrop Industrie
|
France
|
N/A
|
Sanofi-Aventis Philippines, Inc.
|
N/A
|
Renewal (Correction)
|
29 August 2023
|
15 April 2026
|
| View |
|
BR-798
|
Enoxaparin Sodium
|
Clexane
|
6000 IU (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (S.C.)
|
Prescription Drug (RX)
|
0.6 mL in 1 mL pre-filled syringe with needle (Box
of l's and 2's)
|
Antithrombotic Agents
|
Sanofi Winthrop Industrie
|
France
|
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
Renewal
|
01 June 2021
|
15 April 2026
|
| View |
|
BR-799
|
Enoxaparin (as sodium)
|
Clexane
|
2000 IU (equivalent to 20 mg)/0.2 mL
|
Solution For Injection (S.C.)
|
Prescription Drug (RX)
|
0.2 mL in 0.5 mL Pre-filled Glass Syringe with
Needle (Box of l's and 2's)
|
-
|
Sanofi Winthrop Industrie
|
France
|
N/A
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
Renewal (Correction)
|
29 August 2023
|
15 April 2026
|
| View |
|
BR-80
|
Factor VIII
|
Koate DVI
|
50 I.U./mL (250 I.U./15 mL)
|
Lyophilized Powder for Injection (IV)
|
Prescription Drug (RX)
|
Glass vial + SWFI diluent x 5 mL + filter needle +
double-ended transfer needle + administration set (Box of l's)
|
-
|
Grifols Therapeuitcs, Inc.
|
U.S.A
|
N/A
|
GB Distributors, Inc.
|
GB Distributors, Inc.
|
-
|
18 March 2022
|
07 March 2026
|
| View |
|
BR-800
|
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
|
Synflorix
|
0.5mL
|
Suspension For Injection
|
Prescription Drug (RX)
|
0.5mL in 3mL Type I glass vial with a stopper (butyl rubber)
|
Pneumococcal Vaccine
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
|
Glaxosmithkline Philippines, Inc.
|
Glaxosmithkline Philippines, Inc.
|
Renewal
|
19 March 2024
|
15 April 2029
|
| View |
|
BR-801
|
Human Tetanus Immunoglobulin
|
Ig Tetano
|
250 IU/mL
|
Solution For Injection (IM)
|
Prescription Drug (RX)
|
1 mL Type I Pre-filled Glass Syringe with Needle (Box of 1’s)
|
Immunoglobulin
|
Kedrion S.p.A.
|
Italy
|
|
New Marketlink Pharmaceutical Corporation
|
Metro Drug, Inc.
|
Renewal
|
30 March 2021
|
20 April 2026
|
| View |
|
BR-807
|
Tetanus Antitoxin (equine)
|
Sharjvax
|
10000 IU/10 mL (1000 IU/mL)
|
Solution for Injection (IM)
|
Prescription Drug (RX)
|
Clear glass ampoules x 10 mL (Box of 10's)
|
-
|
Jiangxi Institute of Biological Products
|
China
|
N/A
|
Sahar International Trading Inc.
|
Sahar International Trading Inc.
|
Renewal (Reconstruction)
|
07 March 2023
|
26 May 2026
|
| View |
|
BR-808
|
Tetanus Antitoxin (equine)
|
Sharjvax
|
5000 IU/2mL
|
Solution For Injection (I.M)
|
Prescription Drug (RX)
|
Clear glass ampoules x 2 mL (Box of 10's)
|
-
|
Jiangxi Institute of Biological Products
|
China
|
N/A
|
Sahar International Trading Inc.
|
Sahar International Trading Inc.
|
BR-808
|
07 March 2023
|
26 May 2026
|
| View |
|
BR-809
|
Tetanus Antitoxin (equine)
|
Sharjvax
|
3000 IU/0.95 mL
|
Solution For Injection (I.M)
|
Prescription Drug (RX)
|
Clear glass ampoules x 0.95 mL (Box of 10's)
|
-
|
Jiangxi Institute of Biological Products
|
China
|
N/A
|
Sahar International Trading Inc.
|
Sahar International Trading Inc.
|
Renewal (Reconstruction)
|
07 March 2023
|
26 May 2026
|